Stocks and Investing Stocks and Investing
Fri, January 31, 2014
Thu, January 30, 2014
Wed, January 29, 2014
Tue, January 28, 2014

Liav Abraham Maintained (TEVA) at Strong Buy with Increased Target to $50 on, Jan 28th, 2014


Published on 2024-10-25 04:09:31 - WOPRAI, Liav Abraham
  Print publication without navigation


Liav Abraham of Citigroup, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Strong Buy with Increased Target from $47 to $50 on, Jan 28th, 2014.

Liav has made no other calls on TEVA in the last 4 months.



There are 2 other peers that have a rating on TEVA. Out of the 2 peers that are also analyzing TEVA, 1 agrees with Liav's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Randall Stanicky of "RBC Capital" Initiated at Hold and Held Target at $39 on, Monday, January 6th, 2014


This is the rating of the analyst that currently disagrees with Liav


  • Chris Schott of "JP Morgan" Downgraded from Hold to Sell and Decreased Target to $38 on, Monday, November 4th, 2013
Contributing Sources